Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Circulating donor-derived cell-free DNA: a true biomarker for cardiac allograft rejection?

Literature DB >> 25861602

Circulating donor-derived cell-free DNA: a true biomarker for cardiac allograft rejection?

Kevin P Daly¹.

Abstract

Entities: Species

Year: 2015 PMID： 25861602 PMCID： PMC4381466 DOI： 10.3978/j.issn.2305-5839.2015.01.35

Source DB: PubMed Journal: Ann Transl Med ISSN： 2305-5839

× No keyword cloud information.

20 in total

1. Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience.

Authors: Clifford Chin; David C Naftel; Tajinder P Singh; Elizabeth D Blume; Helen Luikart; Daniel Bernstein; Pat Gamberg; James K Kirklin; W Robert Morrow
Journal: J Heart Lung Transplant Date: 2004-02 Impact factor: 10.247

2. Rejection with hemodynamic compromise in the current era of pediatric heart transplantation: a multi-institutional study.

Authors: Melanie D Everitt; Elfriede Pahl; Kenneth B Schechtman; Jie Zheng; Jeremy M Ringewald; Thomas L'ecuyer; David C Naftel; James K Kirklin; Elizabeth D Blume; Emily A Bullock; Charles E Canter
Journal: J Heart Lung Transplant Date: 2010-10-25 Impact factor: 10.247

3. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.

Authors: Susan Stewart; Gayle L Winters; Michael C Fishbein; Henry D Tazelaar; Jon Kobashigawa; Jacki Abrams; Claus B Andersen; Annalisa Angelini; Gerald J Berry; Margaret M Burke; Anthony J Demetris; Elizabeth Hammond; Silviu Itescu; Charles C Marboe; Bruce McManus; Elaine F Reed; Nancy L Reinsmoen; E Rene Rodriguez; Alan G Rose; Marlene Rose; Nicole Suciu-Focia; Adriana Zeevi; Margaret E Billingham
Journal: J Heart Lung Transplant Date: 2005-06-20 Impact factor: 10.247

4. The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation.

Authors: Gerald J Berry; Margaret M Burke; Claus Andersen; Patrick Bruneval; Marny Fedrigo; Michael C Fishbein; Martin Goddard; Elizabeth H Hammond; Ornella Leone; Charles Marboe; Dylan Miller; Desley Neil; Doris Rassl; Monica P Revelo; Alexandra Rice; E Rene Rodriguez; Susan Stewart; Carmela D Tan; Gayle L Winters; Lori West; Mandeep R Mehra; Annalisa Angelini
Journal: J Heart Lung Transplant Date: 2013-12 Impact factor: 10.247

5. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors: David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson; Harmon S Jordan; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal: Circulation Date: 2013-11-12 Impact factor: 29.690

6. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors: Ezra A Amsterdam; Nanette K Wenger; Ralph G Brindis; Donald E Casey; Theodore G Ganiats; David R Holmes; Allan S Jaffe; Hani Jneid; Rosemary F Kelly; Michael C Kontos; Glenn N Levine; Philip R Liebson; Debabrata Mukherjee; Eric D Peterson; Marc S Sabatine; Richard W Smalling; Susan J Zieman
Journal: Circulation Date: 2014-09-23 Impact factor: 29.690

7. The registry of the International Society for Heart and Lung Transplantation: seventeenth official pediatric heart transplantation report--2014; focus theme: retransplantation.

Authors: Anne I Dipchand; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Fabienne Dobbels; Bronwyn J Levvey; Lars H Lund; Bruno Meiser; Roger D Yusen; Josef Stehlik
Journal: J Heart Lung Transplant Date: 2014-08-14 Impact factor: 10.247

8. Alemtuzumab (Campath 1H) as successful salvage therapy for recurrent steroid-resistant heart transplant rejection.

Authors: Kenneth J Woodside; Scott D Lick
Journal: J Heart Lung Transplant Date: 2007-07 Impact factor: 10.247

9. Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection.

Authors: Iwijn De Vlaminck; Hannah A Valantine; Thomas M Snyder; Calvin Strehl; Garrett Cohen; Helen Luikart; Norma F Neff; Jennifer Okamoto; Daniel Bernstein; Dana Weisshaar; Stephen R Quake; Kiran K Khush
Journal: Sci Transl Med Date: 2014-06-18 Impact factor: 17.956

10. Highly sensitive noninvasive cardiac transplant rejection monitoring using targeted quantification of donor-specific cell-free deoxyribonucleic acid.

Authors: Mats Hidestrand; Aoy Tomita-Mitchell; Pip M Hidestrand; Arnold Oliphant; Mary Goetsch; Karl Stamm; Huan-Ling Liang; Chesney Castleberry; D Woodrow Benson; Gail Stendahl; Pippa M Simpson; Stuart Berger; James S Tweddell; Steven Zangwill; Michael E Mitchell
Journal: J Am Coll Cardiol Date: 2013-10-16 Impact factor: 24.094

5 in total

Circulating donor-derived cell-free DNA: a true biomarker for cardiac allograft rejection?

1. Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience.

2. Rejection with hemodynamic compromise in the current era of pediatric heart transplantation: a multi-institutional study.

3. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.

4. The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation.

5. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

6. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

7. The registry of the International Society for Heart and Lung Transplantation: seventeenth official pediatric heart transplantation report--2014; focus theme: retransplantation.

8. Alemtuzumab (Campath 1H) as successful salvage therapy for recurrent steroid-resistant heart transplant rejection.

9. Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection.

10. Highly sensitive noninvasive cardiac transplant rejection monitoring using targeted quantification of donor-specific cell-free deoxyribonucleic acid.

Review 1. Novel Biomarker Approaches for Managing Patients With Cardiac Transplantation.

Review 2. Personalized treatment in heart transplantation.

3. Role of Clinicogenomics in Infectious Disease Diagnostics and Public Health Microbiology.

Review 4. Myriad Applications of Circulating Cell-Free DNA in Precision Organ Transplant Monitoring.

5. Simultaneous Discovery of Cell-Free DNA and the Nucleosome Ladder.